Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-08
2008-07-08
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S314000, C514S362000, C514S365000, C514S374000, C514S372000, C514S414000, C546S146000, C546S159000, C548S181000, C548S233000, C548S245000, C548S454000
Reexamination Certificate
active
07396838
ABSTRACT:
A method of treating cancer including administering to a subject in need thereof an effective amount of a compound of the formula 1:wherein R1, R2, R3, R4, and n are as defined herein.
REFERENCES:
patent: 2825734 (1958-03-01), Speeter
patent: 3351630 (1967-11-01), Shen
patent: 5192770 (1993-03-01), Clark et al.
patent: 6008231 (1999-12-01), Lebaut et al.
patent: 6114355 (2000-09-01), D'Amato
patent: 6232327 (2001-05-01), Nickel et al.
patent: 6251923 (2001-06-01), Höfgen et al.
patent: 6469006 (2002-10-01), Blair et al.
patent: 6613794 (2003-09-01), Hofgen et al.
patent: 198 18 964 (1999-11-01), None
patent: 0 675 110 (1995-10-01), None
patent: 1028812 (1966-05-01), None
patent: 57006878 (1982-01-01), None
patent: 6502481 (1965-02-01), None
patent: WO 99/51224 (1999-10-01), None
patent: WO 02/08225 (2002-01-01), None
patent: WO 03/022280 (2003-03-01), None
In re Rainer, 146 USPQ 218 (1965).
In re Colianni, 195 USPQ 150, Ex parte Formal, 230 USPQ 546.
In re Fisher, 427 F.2d 833, 839; 166 USPQ 18, 24 (CCPA 1970).
In re Wright, 999 F.2d 1557, 1562; 27 USPQ2d 1510, 1513 (Fed. Cir. 1993).
Draetta, G et. al., Annual Rports in medicinal Chemistry, vol. 31, 1996, p. 241-246.
Brown et. al., Oncol Res. 1997, 9(5), p. 213-215.
Weinstein et. al., Science, 1997, 275(5298), p. 343-349.
Hamburger et. al., JNCL, 66 (6) 1981, p. 981-986.
Patterson, A.M. et al., “The Ring Index, 2ndEd.”, American Chemical Society, Columbum, OH 1960, entry #2527, p. 326.
Draetta, G. and Pagano, M. in “Annual Reports in Medicinal Chemistry”, vol. 31, Academic Press, San Diego, pp. 241-246, 1996.
Brown JM, Oncol Res. 9(5):213-5, 1997.
Weinstein JN, et al., Science, 17;275(5298):343-9, 1997.
Hamburger, Anne W., JNCI, 66(6), pp. 981-986, 1981.
Chen Chiung-Tong
Chen Shu-Jen
Hsu Ming-Chu
Hwang Der-Ren
Li Wen-Tai
Murray Jeffrey H
National Health Research Institutes
Occhiuti Rohlicek & Tsao LLP
Wilson James O.
LandOfFree
Use of 1H-indol-3-yl-2-oxoacetamide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 1H-indol-3-yl-2-oxoacetamide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1H-indol-3-yl-2-oxoacetamide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2796042